Clinical evaluation of computer-assisted self-monitoring of blood XXXX system.

@entity1 @entity1723 @entity413 @entity6
The @entity6 Management System includes a @entity413 -reflectance meter with memory that can interface with a microcomputer for data manipulation and analysis. We evaluated the system in a short-term randomized control trial to determine its impact on metabolic control, self-monitoring of blood @entity413 (SMBG) testing behaviors, regimen self-adjustment, understanding of @entity1723 ( @entity1723 ) treatment, attitudes about SMBG, and perceived quality of @entity1 -physician interaction. Twenty-nine adolescent subjects (experimental) with @entity1723 were randomly assigned the Glucometer M system for 4 mo. Twenty-eight control subjects used meters without memory. All subjects returned twice to the clinic at 2-mo intervals during the study. At clinic visits, both groups reviewed their SMBG data with their physician. Reviews on experimental subjects were conducted with computer-generated data formats. Control subject reviews used traditional logbooks. Both groups showed a significant drop in glycosylated hemoglobin during the study period (P less than .001); however, there were no between-group differences. There were also no differences in SMBG testing behavior or self-reported regimen self-adjustment between groups or within groups compared with baseline. Compared with control subjects, experimental subjects indicated a significant increase in self-reported understanding of @entity1723 treatment (P = .002), perceived importance of testing (P = .006), and the quality of interaction with their physician (P less than .001). These data suggest that use of computer-assisted SMBG systems in the outpatient setting does not improve metabolic control over 4 mo. It may, however, contribute to improving communication between the @entity1 and health-care providers.
